When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Kadmon Holdings (NYSE:KDMN) is up 41% premarket on light volume on the heels of updated results from a Phase 2 clinical trial evaluating KD025 in patients with previously treated chronic graft-versus-host disease (GvHD). The data were presented at ASH in San Diego.
More news on: Kadmon Holdings, Healthcare stocks news, Stocks on the move,